# ToleroMune Grass Exposure Unit Study

> **NCT01385800** · PHASE2 · COMPLETED · sponsor: **Circassia Limited** · enrollment: 280 (estimated)

## Conditions studied

- Grass Allergy
- Rhinoconjunctivitis

## Interventions

- **BIOLOGICAL:** ToleroMune Grass
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT01385800
- **Lead sponsor:** Circassia Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2013-07
- **Final completion:** 2013-08
- **Target enrollment:** 280 (ESTIMATED)
- **Last updated:** 2013-08-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01385800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01385800, "ToleroMune Grass Exposure Unit Study". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT01385800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*